Zalcitabine
Generic Name: zalcitabine
Manufactured by ROCHE. Dosage form: TABLET. Route: ORAL. Active ingredients: ZALCITABINE (0.375MG). Application: NDA020199.
Overview
Manufactured by ROCHE. Dosage form: TABLET. Route: ORAL. Active ingredients: ZALCITABINE (0.375MG). Application: NDA020199.
Dosage
Available as tablet for oral use.
Related Medications
1.1% Sodium Fluoride
1.1% sodium fluoride
DESCRIPTION Self-topical neutral fluoride gel containing 1.1% (w/v) sodium fluoride for use as a dental caries preventive in pediatric patients and adults. This prescription product is not a dentifrice. Active Ingredient: Sodium Fluoride, USP 1.1% (w/v).
Atovaquone And Proguanil Hydrochloride Pediatric
atovaquone and proguanil hydrochloride pediatric
Antimalarial [EPC]
11 DESCRIPTION Atovaquone and proguanil hydrochloride tablets (adult strength) and Atovaquone and proguanil hydrochloride pediatric tablets, for oral administration, contain a fixed-dose combination of the antimalarial agents atovaquone, USP and proguanil hydrochloride, USP. The chemical name of atovaquone, USP is trans -2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione.
Sumatriptan
sumatriptan
11 DESCRIPTION Sumatriptan Injection, USP contains sumatriptan succinate, a selective 5-HT 1B/1D receptor agonist. Sumatriptan succinate is chemically designated as 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide succinate (1:1), and it has the following structure: The empirical formula is C 14 H 21 N 3 O 2 S•C 4 H 6 O 4 , representing a molecular weight of 413.5. Sumatriptan succinate, USP is a white to off-white powder that is readily soluble in water and in saline.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.